DEA Meetings & Events
Upcoming Events:
Quota Virtual Diversion Awareness Training
DAYS: April 2, 7,8,9,16, 2026 | 1:00 p.m. to 2:00 p.m. EST | ZOOM - Webinar Platform
The Diversion Control Division (DCD) of the Drug Enforcement Administration (DEA) is pleased to present a series of five (5) webinars covering supply chain matters relating to quota. This training primarily focuses on manufacturers, distributors, and importers of schedule I and II controlled substances and certain list I chemicals (ephedrine, pseudoephedrine, and phenylpropanolamine). You may register for any or all of the following webinars of interest to you or your business.
There is no registration fee for these events. Capacity is limited to the first 3,000 attendees.
Thursday, April 2: International Treaties/Controlled Substances Act
Summary: Discussion regarding the relationship between the 1961 Single Convention, 1971 Psychotropic Convention, 1988 Precursor Chemical Convention and the Controlled Substances Act (CSA); DEA's responsibilities regarding quota management under the three drug control treaties and the CSA; and how DEA communicates with the public regarding the three drug control treaties and the CSA.
Speaker: Sandy G. Ghozland, Drug Science Specialist, UN Reporting and Quota
Important Notice: This webinar is a two-part registration process. Please complete both steps to confirm your attendance.
Register Now for the Virtual Webinar
Confirmation of registration will be sent to each attendee's email address.
Any questions regarding this conference may be directed to: VDAT@dea.gov
Tuesday, April 7: Aggregate Production Quota (APQ) and Assessment of Annual Needs (ANN) for List for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine
Summary: Discussion regarding drug control under the Controlled Substances Act (CSA), description and purpose of the Aggregate Production Quota (APQ) and Assessment of Annual Needs (AAN), the factors DEA considers when building the APQ and AAN and their relationship to the allotment of individual manufacturing, procurement, and importation quotas, as well as the factors DEA considers in adjudicating individual manufacturing, procurement, and importation quotas.
Speaker: Paul S. Loor, Drug Science Specialist, UN Reporting and Quota
Important Notice: This webinar is a two-part registration process. Please complete both steps to confirm your attendance.
Register Now for the Virtual Webinar
Confirmation of registration will be sent to each attendee's email address.
Any questions regarding this conference may be directed to: VDAT@dea.gov
Wednesday, April 8: Quota Management System (QMS) Online
Summary: Discussion on why the Quota Management System (QMS) was developed; the user interface display and specific considerations regarding manufacturing, procurement, or import quotas requests; and guidance to registrants regarding the submission of data necessary to adjudicate individual quota applications.
Speaker: Miessa Brown, Drug Science Specialist, UN Reporting and Quota
Important Notice: This webinar is a two-part registration process. Please complete both steps to confirm your attendance.
Register Now for the Virtual Webinar
Confirmation of registration will be sent to each attendee's email address.
Any questions regarding this conference may be directed to: VDAT@dea.gov
Thursday, April 9: Year End Reports System (YERS) Online
Summary: Discussion on why the Year-End Reporting System (YERS) was developed; specific user interface displays for manufacturing, procurement, or import data submission; how the data will be utilized to demonstrate U.S. compliance with the three UN drug control treaties and domestic adherence to the CSA and its conforming regulations.
Speaker: Karon A. Hall, Drug Science Specialist, UN Reporting and Quota
Important Notice: This webinar is a two-part registration process. Please complete both steps to confirm your attendance.
Register Now for the Virtual Webinar
Confirmation of registration will be sent to each attendee's email address.
Any questions regarding this conference may be directed to: VDAT@dea.gov
Thursday, April 16: Research vs Manufacturing
Summary: Discussion regarding the difference between research and manufacturing of controlled substances under the Controlled Substances Act (CSA) and its implementing regulations; and clarification of what coincidental activities may occur under each DEA registration.
Speaker: Gregory J. Kavanagh, Drug Science Specialist, UN Reporting and Quota
Important Notice: This webinar is a two-part registration process. Please complete both steps to confirm your attendance.
Register Now for the Virtual Webinar
Confirmation of registration will be sent to each attendee's email address.
Any questions regarding this conference may be directed to: VDAT@dea.gov
DEA Washington Division- Lunch & Learn Web-series: “Strengthening our Partnerships” Imports / Exports - Key Issues Impacting the Synthetic Drug Threat
Friday, April 24, 2026| 1:00 – 1:30 PM EST| WebEx - Webinar Platform
Join the DEA Washington Division for our ongoing Lunch and Learn Web-Series: “Strengthening Our Partnerships.” Each month, we host 30-minute LIVE sessions featuring DEA speakers and special guests who present and discuss critical information, regulations, and procedures related to the handling, dispensing, manufacturing, distribution, and prescribing of Controlled Substances. These sessions aim to prevent diversion and reduce drug overdoses and poisonings in the District of Columbia, Maryland, and Virginia (DMV).
The import and export of synthetic drugs and their precursor chemicals represent a complex, globalized supply chain issue, driven by the rapid shipment of chemical inputs primarily from Asia to manufacturing hubs, often in Mexico, before entering the United States.
Moderator: Justin G. Wood - Diversion Program Manager, DEA Washington Division
Speaker: Jacob P. Prieto - Section Chief – DEA HQS- Diversion Control Division Import/Export Section (DRI)
Audience: DEA Registrants, healthcare professionals, administrative and support personnel, local/state government officials, and students pursuing healthcare-related careers.
Registration is required. There is no registration fee. These are LIVE events and not recorded. The program is informational only and not for credit.
Any questions regarding these events may be directed to Lillianect Rivas-Mattei, Diversion Program Specialist (Outreach Coordinator) via email to WashingtonDiversionOutreach@dea.com.
Virtual Registration: WebEx Webinars
(capacity is limited to the first 1000 attendees)
1st VETERINARY MEDICINE CONFERENCE- Maryland
Wednesday, April 30, 2026 | 10:00 PM- 11:30 AM - Virtual
The Drug Enforcement Administration (DEA) Washington Division - Baltimore District Office, is excited to host its 1st Veterinary Medicine Regulatory Conference in Maryland. This event will cover federal information, regulations, and procedures related to the proper handling of controlled substances.
Target Audience: This conference is specifically designed for:
- Veterinarians
- Veterinary Technicians
- Support personnel involved in direct patient care in Maryland.
Topics:
- Registration: Veterinary-in-Charge | Transfer| Cancelations
- Ordering Forms and Procedures
- Transferring CS | Inventory and Record-Keeping Requirements
- Drug Destruction: Pharmaceutical vs. Stock Waste
Moderator: Justin G. Wood- Diversion Program Manager, DEA Washington Division
Virtual Registration: WebEx Webinars
Registration is required. There is no registration fee. This is a LIVE event and not recorded. The program is informational and not for credit.
The contents of the presentations, to include speaker remarks, do not have the force and effect of law and are not meant to bind the public in any way. It is intended only for educational purposes to provide clarity to the public regarding existing resources or requirements under the law or agency policies. The statements contained during the summit that are not embodied in the law are not binding on DEA.
Any questions regarding these events may be directed to Lillianect Rivas-Mattei, Diversion Program Specialist (Outreach Coordinator) via email to WashingtonDiversionOutreach@dea.com.
2026 Pharmacy Diversion Awareness Conference (PDAC)
Friday, May 1, 2026, OR Saturday, May 2, 2026 | 8:30 a.m. – 5:00 p.m. | In-person
You are cordially invited to the 2026 Pharmacy Diversion Awareness Conference (PDAC), a crucial one-day educational event designed to equip you with the tools, knowledge, and strategies to identify and prevent the diversion of controlled substances.
As professionals on the front lines of healthcare, your role is vital in ensuring the proper, legal, and safe dispensing of medication. With evolving DEA regulations and emerging fraud risks heading into 2026, this conference provides critical updates to keep your practice compliant and safe.
Conference Highlights & Agenda
This one-day, in-person event offers approximately seven hours of instruction, featuring expert speakers from the DEA, regulatory boards, and industry leaders. See Agenda for details.
- Recognizing Red Flags: Identifying forged prescriptions and doctor-shopping behaviors
- DEA Compliance & Audits: Understanding your obligations regarding inventory, records, and reports
- Evolving Trends in 2026: Addressing new risks in the pharmacy space and mitigating legal exposure
- Best Practices for Prevention: Implementing a robust drug diversion prevention program
Event Details
- Date: Choose either Friday, May 1, 2026, OR Saturday, May 2, 2026 (same agenda both days)
- Time: 8:30 a.m. – 5:00 p.m.
- Location: DoubleTree by Hilton Lansing, 111 North Grand Avenue, Lansing, Michigan 48933
- Registration Fee: Free for pharmacists, pharmacy technicians, and loss prevention personnel
- Continuing Education: ACPE-accredited continuing pharmacy education hours are available upon completion
Why Attend?
Drug diversion contributes to abuse, overdose, and death, with the opioid crisis continuing to impact our communities. This conference will empower you to make a difference by securing your pharmacy against unauthorized drug distribution, protecting both your patients and your professional license.
Space is limited. Please register by April 30, 2026, to secure your spot!
Confirmation of registration will be sent to each attendee's email address. In-person attendees should print the confirmation email and bring it to the conference for easy check-in.
Any questions regarding this conference may be directed to: DEADetroitDiversionOutreach@dea.gov
